The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.
DUBAI / WAM
M42 — a first-of-its-kind health powerhouse committed to reshaping the sustainable future of health with technology as a key enabler — and Broad Institute of MIT and Harvard will work with Microsoft and the International Center for Genetic Disease. The group will leverage the Terra platform to explore scenarios for precision health discovery and delivery, collaborating with healthcare organisations across the global ecosystem. Terra, which will be deployed on the UAE cloud with sovereign capabilities powered by Microsoft Azure, will be used not only as a Trusted Research Environment, but also as the foundation for M42’s Global Life Sciences Platform.
This supports the intent to advance M42’s data science capabilities for clinical and genomic data integration, access and research, and to improve patient lives and inform scientific research across the world.
Foundational projects include a best-in-practice Trusted Research Environment — a cutting-edge technology platform that enables life science research through stringent and secure data access workflows. Terra — a secure, scalable, open-source platform for biomedical researchers to access data, run analysis tools and collaborate — will provide the foundational technology to enable data science, life science and precision medicine growth in the UAE, while contributing to the availability of more diverse genomic datasets for human health research globally. Terra was co-developed by Broad Institute, Microsoft, and Verily.
M42’s Global Life Sciences Platform will leverage existing Microsoft Azure Health Data Services, generative AI-based data models, host advanced tools including M42’s generative AI model, Med42, and drive interoperability and advanced analytics for both research and clinical care.